Business Context and Reporting Period
Company: InMode Ltd. (INMD)
Filing Type: Annual Report on Form 20-F
Reporting Period: Fiscal year ended December 31, 2024
Business Overview: InMode is a global provider of innovative, energy-based, minimally invasive surgical and non-invasive medical aesthetic treatment solutions. The company utilizes proprietary Radio Frequency (RF) technologies for face and body contouring, medical aesthetics, and women's wellness. It operates primarily through a direct sales force in the U.S., Canada, and select international markets, alongside a network of distributors in over 85 countries.
Key Financial Metrics (Year Ended Dec 31, 2024)
| Metric | 2024 (USD) | 2023 (USD) | Change |
|---|---|---|---|
| Total Revenue | $394.8 million | $492.0 million | -20% |
| Gross Profit | $317.1 million | $411.3 million | -23% |
| Gross Margin | 80% | 84% | -400 bps |
| Operating Income | $112.5 million | $195.7 million | -43% |
| Net Income | $181.3 million | $197.9 million | -8% |
| Diluted EPS | $2.25 | $2.30 | -2% |
| Cash & Equivalents | $155.3 million | $144.4 million | +8% |
| Total Liquidity (Cash, Securities, Deposits) | $596.5 million | $741.6 million | -19% |
| Share Repurchases (2024) | $285.4 million | $0 | N/A |
Note: The filing text does not provide a specific "Debt" figure as the company has no outstanding borrowings. Total liabilities were $81.9 million, primarily consisting of operating lease liabilities and contract liabilities.
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased by $97.2 million (20%) driven by a global slowdown in demand for aesthetic procedures and challenging financing markets.
- Minimally Invasive Platforms: Decreased by $62.6 million (15%).
- Hands-Free Platforms: Decreased by $23.0 million (53%).
- Non-Invasive Platforms: Decreased by $11.7 million (28%).
- Geographic Performance: U.S. revenue fell 20% to $244.8 million. International revenue fell 19% to $150.0 million.
- Margin Compression: Gross margin decreased from 84% to 80% due to increased material costs and a shift in sales mix between the U.S. and the rest of the world.
- Income Tax Benefit: The company recorded a tax benefit of $37.8 million in 2024 (vs. an expense of $19.3 million in 2023), primarily due to the release of a $60.1 million valuation allowance on U.S. net deferred tax assets.
- Capital Allocation: The company aggressively returned capital to shareholders, repurchasing 16.05 million shares for $285.4 million in 2024.
Guidance, Outlook, Risks, and Unusual Items
- Outlook: Management expects continued growth in consumables and extended warranty revenues as the installed base grows. The company plans to expand its direct sales force and introduce next-generation pipeline products.
- Geopolitical Risks: The ongoing Israel-Hamas war and regional conflicts pose significant risks to operations, supply chain, and employee availability. While the impact was deemed immaterial in 2024, escalation could disrupt manufacturing and logistics.
- Legal Proceedings: A putative shareholder class action was filed in February 2024 alleging false statements regarding business operations and financial outlook. The company intends to vigorously defend the claims; no liability has been recorded as the outcome is uncertain.
- Regulatory Risks: The company relies on FDA 510(k) clearances. Changes in regulatory policy or failure to maintain compliance could restrict commercial operations.
- Unusual Items: The significant tax benefit in 2024 was driven by a non-cash release of valuation allowances, which boosted net income despite the decline in operating income.
Key Facts for Investor Verification
- Revenue Mix Shift: Verify the sustainability of the decline in hands-free platform revenue (-53%) and whether this is a temporary market correction or a structural shift.
- Geopolitical Exposure: Assess the specific impact of the Israel-Hamas conflict on the company's three primary manufacturing subcontractors located in Israel and potential supply chain disruptions.
- Share Repurchase Impact: Confirm the remaining authorization under the May and September 2024 repurchase programs and the company's liquidity position post-repurchase ($596.5 million total liquidity).
- Tax Position: Understand the permanence of the U.S. deferred tax asset release and the reliance on future profitability to realize these assets.
- Installed Base: Verify the growth rate of the global installed base (approx. 27,090 platforms as of Dec 31, 2024) as a leading indicator for recurring consumable revenue.